BEGIN:VCALENDAR
VERSION:2.0
PRODID:com.k4socal.site
BEGIN:VEVENT
UID:DD Call with Pharma in silica-2026-01-29 17:00:00 UTC@k4socal.com
DTSTAMP:20260621T123948Z
DTSTART:20260129T170000Z
DTEND:20260129T183000Z
SUMMARY:Pharma in silicaPharma in silica’s precision chemotherapy attacks solid tumors while sparing patients painful, maiming and costly adverse effects imposed by current chemo. OpPacli™ is fifteen months to FDA Phase Ib/IIa 515(b)(2) clinical trial against NSCLC. In 2028, the nanocarrier platform will enable pharmas to capture the chemo drugs US$ 25B market.
DESCRIPTION:Join us for the Virtual Forum Meeting: https://k4socal.zoom.us/meeting/register/ZNSAyb3HRGiDcEOpy9jhBQ
URL;VALUE=URI:https://k4socal.zoom.us/meeting/register/ZNSAyb3HRGiDcEOpy9jhBQ
END:VEVENT
END:VCALENDAR